Manufacturer’s Part Number: RK041D
Product size: Kit of 32 tests
Clearance: CE / HCL

Price: $950.00


Product Description

In EU: This Product is CE Marked.

Health Canada Licensed.

Enzyme immuno-assay designed for measuring globally all heparin-dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma or serum, or in any biological fluid where these antibodies must be measured. This assay is proposed as screening, as an early identification of heparin treated patients presenting a risk to develop HIT or HITT. This assay measures the whole of antibodies. It offers the highest sensitivity as all isotypes are detected. It is the preferred assay when an early detection of heparin dependent antibodies is required for assessing the development risk of HIT/HITT.

This kit allows individual testing as it offers a packaging for 4 individual 8 well strips along with controls.

This is an ON-DEMAND item which requires minimum order quantity and extended lead time. Please Contact Us for a quote.

Product Characteristics

  • Total Assay Time: 2 hr 15 min
  • Cut Off: A450 ≥ 0.50
  • Dynamic Range: A450 up to 3.0
  • Intra-Assay CV: 4 - 6%
  • Inter-Assay CV: 5 - 8%

Product Components

  • Micro ELISA Plate (4 strips of 8 wells)
  • 2x HIA Sample Diluent.
  • 4 x HIA IgGAM Positive Control
  • 4 x Negative Control
  • 4 x Platelet Lysate
  • 4 x Anti-IgG (Fcγ)-IgM (µ)-IgA(α)-HRP IC
  • 1 x Conjugate Diluent
  • 4x Wash Solution
  • 1 x TMB
  • Video of Product Components
    (Video can be viewed with Flash Plugin)

Product Applications

Individual test.

Assessment of the risk to develop HIT/HITT, in patients treated with heparins (Unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT.

Clinical suspicion of HIT during heparin therapy.

Data Sheet/Technical Data

Certificate of Analysis (COA)

Other Documents